319.83
Overview
News
Price History
Option Chain
Financials
Discussions
Forecast
Stock Split
Dividend History
Waters Corp stock is traded at $319.83, with a volume of 3.48M.
It is down -2.85% in the last 24 hours and down -18.76% over the past month.
Water sells liquid chromatography, mass spectrometry, and thermal analysis tools. These analytical instruments provide essential information on various products, such as their molecular structures and physical properties, to help clients enhance the health and well-being of end users. As a percentage of sales in 2024, Waters generated 58% from biopharmaceutical customers, 31% from industrial clients, and 11% from academic/government institutions. In early 2026, Waters plans to merge with BD's life science and diagnostics business, which will substantially change those concentrations. Waters will wind up with more concentration in diagnostics (versus none now) and discovery-related life science tools.
See More
Previous Close:
$329.20
Open:
$328.685
24h Volume:
3.48M
Relative Volume:
4.87
Market Cap:
$31.37B
Revenue:
$3.17B
Net Income/Loss:
$642.63M
P/E Ratio:
29.71
EPS:
10.7666
Net Cash Flow:
$539.81M
1W Performance:
-15.14%
1M Performance:
-18.76%
6M Performance:
+12.02%
1Y Performance:
-16.26%
Waters Corp Stock (WAT) Company Profile
Name
Waters Corp
Sector
Industry
Phone
(508) 478-2000
Address
34 MAPLE ST, MILFORD, MA
Compare WAT vs TMO, DHR, IDXX, A
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
|
WAT
Waters Corp
|
319.83 | 32.29B | 3.17B | 642.63M | 539.81M | 10.77 |
|
TMO
Thermo Fisher Scientific Inc
|
509.82 | 198.06B | 44.56B | 6.73B | 6.29B | 17.74 |
|
DHR
Danaher Corp
|
214.94 | 155.50B | 24.57B | 3.60B | 5.25B | 5.0475 |
|
IDXX
Idexx Laboratories Inc
|
617.20 | 51.80B | 4.30B | 1.06B | 1.04B | 13.08 |
|
A
Agilent Technologies Inc
|
124.88 | 36.46B | 6.95B | 1.30B | 1.15B | 4.5696 |
Waters Corp Stock (WAT) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Jan-06-26 | Initiated | Guggenheim | Buy |
| Jan-05-26 | Initiated | William Blair | Outperform |
| Dec-10-25 | Upgrade | Wolfe Research | Peer Perform → Outperform |
| Dec-02-25 | Initiated | Morgan Stanley | Equal-Weight |
| Oct-08-25 | Initiated | Rothschild & Co Redburn | Buy |
| Mar-31-25 | Upgrade | KeyBanc Capital Markets | Sector Weight → Overweight |
| Mar-26-25 | Upgrade | Robert W. Baird | Neutral → Outperform |
| Feb-13-25 | Upgrade | Scotiabank | Sector Perform → Sector Outperform |
| Feb-10-25 | Upgrade | Barclays | Underweight → Equal Weight |
| Jan-10-25 | Upgrade | Bernstein | Mkt Perform → Outperform |
| Dec-23-24 | Initiated | Scotiabank | Sector Perform |
| Oct-08-24 | Upgrade | Jefferies | Hold → Buy |
| Aug-28-24 | Initiated | Wells Fargo | Overweight |
| Aug-01-24 | Upgrade | Leerink Partners | Market Perform → Outperform |
| Jun-03-24 | Resumed | Jefferies | Hold |
| Nov-13-23 | Downgrade | Barclays | Equal Weight → Underweight |
| Sep-28-23 | Initiated | Bernstein | Mkt Perform |
| Jul-31-23 | Downgrade | Barclays | Overweight → Equal Weight |
| Jul-31-23 | Downgrade | Evercore ISI | Outperform → In-line |
| Dec-14-22 | Initiated | Deutsche Bank | Hold |
| Aug-25-22 | Initiated | Credit Suisse | Neutral |
| Jul-20-22 | Initiated | UBS | Neutral |
| May-18-22 | Initiated | Barclays | Overweight |
| May-17-22 | Upgrade | BofA Securities | Underperform → Neutral |
| Apr-25-22 | Upgrade | Wells Fargo | Underweight → Equal Weight |
| Oct-15-21 | Resumed | Cowen | Market Perform |
| Jul-06-21 | Upgrade | Evercore ISI | In-line → Outperform |
| Jan-07-21 | Downgrade | Wells Fargo | Equal Weight → Underweight |
| Dec-17-20 | Upgrade | Cleveland Research | Underperform → Buy |
| Dec-16-20 | Upgrade | Citigroup | Sell → Neutral |
| Dec-02-20 | Initiated | Goldman | Neutral |
| Nov-10-20 | Initiated | KeyBanc Capital Markets | Sector Weight |
| Jul-28-20 | Upgrade | JP Morgan | Underweight → Neutral |
| Jul-16-20 | Upgrade | Wells Fargo | Underweight → Equal Weight |
| Jan-08-20 | Downgrade | Needham | Hold → Underperform |
| Jan-08-20 | Initiated | Wells Fargo | Underweight |
| Jan-07-20 | Initiated | Citigroup | Sell |
| Nov-15-19 | Initiated | Stifel | Hold |
| Oct-09-19 | Downgrade | Barclays | Equal Weight → Underweight |
| Jul-16-19 | Downgrade | BofA/Merrill | Neutral → Underperform |
| Jun-12-19 | Downgrade | Cleveland Research | Neutral → Underperform |
| May-30-19 | Initiated | Wolfe Research | Underperform |
| Jan-24-19 | Downgrade | Robert W. Baird | Outperform → Neutral |
| Jan-03-19 | Upgrade | BofA/Merrill | Underperform → Neutral |
| Jan-03-19 | Initiated | Needham | Hold |
| Dec-12-18 | Downgrade | JP Morgan | Neutral → Underweight |
| Nov-30-18 | Downgrade | Goldman | Neutral → Sell |
| Oct-11-18 | Upgrade | Cleveland Research | Sell → Neutral |
View All
Waters Corp Stock (WAT) Latest News
Waters Corporation stock drops again as analysts reset targets after BD deal - Bez Kabli
Waters slips despite Q4 beat as outlook disappoints - MSN
Does Waters Corporation outperform in volatile marketsJuly 2025 Action & Accurate Buy Signal Alerts - baoquankhu1.vn
Waters (WAT) Sees Price Target Downgrade by Wells Fargo | WAT St - GuruFocus
Waters Corporation (NYSE:WAT) Q4 2025 Earnings Call Transcript - Insider Monkey
Waters resumed with an In Line at Evercore ISI - Yahoo Finance
Waters Corporation $WAT Stock Holdings Decreased by Madison Asset Management LLC - MarketBeat
Waters stock price target maintained at $380 by Stifel amid BD integration challenges - Investing.com India
What's Going On With Becton Dickinson Stock Tuesday? - Benzinga
Waters Corp. price target lowered to $370 from $395 at UBS - Investing.com Nigeria
Barclays resumes Waters stock coverage with Overweight rating, $400 target By Investing.com - Investing.com UK
Waters finalizes $19B bioscience division acquisition - Worcester Business Journal
Waters Corp. price target lowered to $370 from $395 at UBS By Investing.com - Investing.com India
Waters Corporation (WAT): Guggenheim Reiterates 'Buy' Rating wit - GuruFocus
Reports Q 2026 Results: Full Earnings Call Transcript - Benzinga
Waters Corp. stock price target lowered to $373 at TD Cowen By Investing.com - Investing.com India
Waters Corp. stock price target lowered to $373 at TD Cowen - Investing.com India
Waters (WAT) Gains Barclays' Favor Following Strategic Acquisiti - GuruFocus
Barclays resumes Waters stock coverage with Overweight rating, $400 target - Investing.com
Waters (WAT) Receives Buy Rating from Citi with $425 Target - GuruFocus
Waters Corporation (WAT) Shares Fall 14.5% Following FY2026 Guidance Despite Q4 Beat - AlphaStreet News
GUARDCAP ASSET MANAGEMENT Ltd Decreases Holdings in Waters Corporation $WAT - MarketBeat
Waters Corporation (WAT) Completes Strategic Merger with BD's Sp - GuruFocus
Waters Corp. shares slide after Q4 earnings report. Here's why - Milford Daily News
Waters Corp Earnings Call: Growth, Risks and Synergies - TipRanks
Waters Corporation (NYSE:WAT) Reports Q4 CY2025 In Line With Expectations - Finviz
Waters stock coverage resumed at Evercore ISI with In Line rating By Investing.com - Investing.com India
Waters stock coverage resumed at Evercore ISI with In Line rating - Investing.com Nigeria
Waters Corp (WAT) Q4 2025 Earnings Call Highlights: Strong Reven - GuruFocus
Waters Corp. stock underperforms Monday when compared to competitors - MarketWatch
Waters Corporation (NYSE:WAT) Surprises Markets With Growth Breadth Across S&P 500 - Kalkine Media
Waters stock drops more than 10% on deal-close day as newly acquired BD business arrives softer than modeled - R&D World
Waters Corp Shares Fall After Low Profit Outlook, Closing of Becton Dickinson Unit Deal - 富途牛牛
Why Is Waters Stock Sinking Monday? - Benzinga
Waters closes deal for BD biosciences/diagnostics assets, reorganizes into four divisions - R&D World
Waters Corporation Is Quietly Eating Wall Street – Is This Sleeper Stock Your Next Power Move? - AD HOC NEWS
Waters Corp shares drop as Q1 profit forecast falls short of estimates - Investing.com Canada
Earnings call transcript: Waters Corp. Q4 2025 beats earnings, stock drops By Investing.com - Investing.com South Africa
Waters Corp falls on weak quarterly profit outlook - TradingView
Stifel reiterates Hold rating on Waters Corp stock amid solid Q4 results - Investing.com Nigeria
Stifel reiterates Hold rating on Waters Corp stock amid solid Q4 results By Investing.com - Investing.com India
Waters forecasts weak first-quarter profit, shares slide - Reuters
Waters Completes Combination with BD's Biosciences & Diagnostic Solutions Businesses - Yahoo Finance
Waters: Q4 Earnings Snapshot - KVUE
Waters Corp (NYSE:WAT) Reports Mixed Q4 2025 Results, Stock Falls on EPS Miss - ChartMill
Waters Corporation Reports Fourth Quarter and Full-Year 2025 Financial Results - TradingView
Waters (WAT) Reports Next Week: Wall Street Expects Earnings Growth - Finviz
Retail Trends: What are the future prospects of Waters CorporationAnalyst Upgrade & Weekly Breakout Stock Alerts - baoquankhu1.vn
Waters Corporation (WAT): A Bull Case Theory - Finviz
Waters Corp Stock (WAT) Financials Data
Revenue
Net Income
Cash Flow
EPS
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):